Company profile for Nevakar

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nevakar is a specialty pharmaceutical company focused on developing innovative ophthalmic and injectable products. Our goal is to create value for the healthcare system by offering products that are accessible and lead to better outcomes for patients.These drug repositioning efforts are focused on: Studying new therapeutic indication of existing molecules, Developing novel or superior formulations, Designing improved, safer & ...
Nevakar is a specialty pharmaceutical company focused on developing innovative ophthalmic and injectable products. Our goal is to create value for the healthcare system by offering products that are accessible and lead to better outcomes for patients.These drug repositioning efforts are focused on: Studying new therapeutic indication of existing molecules, Developing novel or superior formulations, Designing improved, safer & more functional packaging Implementing effective regulatory & clinical strategies that support new uses or indications. These new products with proprietary enhancements are filed with the FDA, primarily under 505(b)(2).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1019 US Highway 202-206, Building K NJ Center of Excellence Bridgewater, NJ 08...
Telephone
Telephone
(908) 367-7400
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/07/03/2698501/0/en/Nevakar-Injectables-Announces-FDA-Approval-of-Cyclophosphamide-RTD-Solution.html

GLOBENEWSWIRE
03 Jul 2023

https://www.prnewswire.com/news-releases/long-grove-pharmaceuticals-secures-commercial-rights-to-an-essential-critical-care-medication-301816518.html

PR NEWSWIRE
04 May 2023

https://www.prnewswire.com/news-releases/endo-acquires-six-development-stage-ready-to-use-injectable-product-candidates-from-nevakar-301537147.html

PRNEWSWIRE
02 May 2022

https://www.globenewswire.com/news-release/2022/05/02/2433367/0/en/Nevakar-Injectables-Sells-Six-Development-Stage-Ready-to-Use-Injectable-Product-Candidates-to-Endo-Ventures-Limited.html

GLOBENEWSWIRE
02 May 2022

https://www.globenewswire.com/news-release/2022/04/28/2431255/0/en/Nevakar-Injectables-Receives-U-S-FDA-Approval-of-Ready-to-Use-Ephedrine-Injection-in-a-Prefilled-Syringe.html

GLOBENEWSWIRE
28 Apr 2022

https://www.globenewswire.com/news-release/2022/03/28/2410876/0/en/Nevakar-Injectables-Announces-the-Launch-of-Ready-to-Use-Ephedrine-Injection-Vials.html

GLOBENEWSWIRE
28 Mar 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty